參考文獻 |
1. Mao, A.S. and D.J. Mooney, Regenerative medicine: Current therapies and future directions. Proceedings of the National Academy of Sciences of the United States of America, 2015. 112(47): p. 14452-14459.
2. Parveen, S., et al., New era in health care: tissue engineering. 2006. 1(1): p. 8.
3. Malard, F. and M.J.M.o.i. Mohty, New insight for the diagnosis of gastrointestinal acute graft-versus-host disease. 2014. 2014.
4. Irfan, A. and I.J.M.E.I. Ahmed, Stem Cells: The Future of Personalised Medicine? 2014. 5: p. MEI. S13177.
5. Dick, J.E.J.B., Stem cell concepts renew cancer research. 2008. 112(13): p. 4793-4807.
6. Papapetrou, E.P., et al., Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proceedings of the National Academy of Sciences of the United States of America, 2009. 106(31): p. 12759-12764.
7. Fischbach, G.D. and R.L. Fischbach, Stem cells: science, policy, and ethics. Journal of Clinical Investigation, 2004. 114(10): p. 1364-1370.
8. Yu, J.Y., et al., Induced pluripotent stem cell lines derived from human somatic cells. Science, 2007. 318(5858): p. 1917-1920.
9. Takahashi, K. and S. Yamanaka, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006. 126(4): p. 663-676.
10. Bonfanti, P., et al., Microenvironmental reprogramming of thymic epithelial cells to skin multipotent stem cells. Nature, 2010. 466(7309): p. 978-U105.
11. Ullah, I., R.B. Subbarao, and G.J. Rho, Human mesenchymal stem cells - current trends and future prospective. Bioscience Reports, 2015. 35: p. 18.
12. Pittenger, M.F., et al., Multilineage potential of adult human mesenchymal stem cells. Science, 1999. 284(5411): p. 143-147.
13. in ′tAnker, P.S., et al., Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood, 2003. 102(4): p. 1548-1549.
14. Tsai, M.S., et al., Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Human Reproduction, 2004. 19(6): p. 1450-1456.
15. Cai, J.L., et al., Generation of Human Induced Pluripotent Stem Cells from Umbilical Cord Matrix and Amniotic Membrane Mesenchymal Cells. Journal of Biological Chemistry, 2010. 285(15): p. 11227-11234.
16. Wagner, W., et al., Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Experimental Hematology, 2005. 33(11): p. 1402-1416.
17. Zhang, X., et al., Runx2 overexpression enhances osteoblastic differentiation and mineralization in adipose - derived stem cells in vitro and in vivo. Calcified Tissue International, 2006. 79(3): p. 169-178.
18. Huang, G.T.J., S. Gronthos, and S. Shi, Mesenchymal Stem Cells Derived from Dental Tissues vs. Those from Other Sources: Their Biology and Role in Regenerative Medicine. Journal of Dental Research, 2009. 88(9): p. 792-806.
19. Seifrtova, M., et al., The response of human ectomesenchymal dental pulp stem cells to cisplatin treatment. International Endodontic Journal, 2012. 45(5): p. 401-412.
20. Schuring, A.N., et al., Characterization of endometrial mesenchymal stem-like cells obtained by endometrial biopsy during routine diagnostics. Fertility and Sterility, 2011. 95(1): p. 423-426.
21. Jiao, F., et al., Human Mesenchymal Stem Cells Derived From Limb Bud Can Differentiate into All Three Embryonic Germ Layers Lineages. Cellular Reprogramming, 2012. 14(4): p. 324-333.
22. Allickson, J.G., et al., Recent studies assessing the proliferative capability of a novel adult stem cell identified in menstrual blood. 2011. 3(2011): p. 4.
23. Ab Kadir, R., et al., Characterization of Mononucleated Human Peripheral Blood Cells. Scientific World Journal, 2012: p. 8.
24. Raynaud, C.M., et al., Comprehensive Characterization of Mesenchymal Stem Cells from Human Placenta and Fetal Membrane and Their Response to Osteoactivin Stimulation. Stem Cells International, 2012: p. 13.
25. Rotter, N., et al., Isolation and characterization of adult stem cells from human salivary glands. Stem Cells and Development, 2008. 17(3): p. 509-518.
26. Bartsch, G., et al., Propagation, expansion, and multilineage differentiation of human somatic stem cells from dermal progenitors. Stem Cells and Development, 2005. 14(3): p. 337-348.
27. Riekstina, U., et al., Characterization of human skin-derived mesenchymal stem cell proliferation rate in different growth conditions. Cytotechnology, 2008. 58(3): p. 153-162.
28. Kita, K., et al., Isolation and Characterization of Mesenchymal Stem Cells From the Sub-Amniotic Human Umbilical Cord Lining Membrane. Stem Cells and Development, 2010. 19(4): p. 491-501.
29. Morito, T., et al., Synovial fluid-derived mesenchymal stem cells increase after intra-articular ligament injury in humans. Rheumatology, 2008. 47(8): p. 1137-1143.
30. Wang, H.S., et al., Mesenchymal stem cells in the Wharton′s jelly of the human umbilical cord. Stem Cells, 2004. 22(7): p. 1330-1337.
31. Hou, T.Y., et al., Umbilical Cord Wharton′s Jelly: A New Potential Cell Source of Mesenchymal Stromal Cells for Bone Tissue Engineering. Tissue Engineering Part A, 2009. 15(9): p. 2325-2334.
32. Goff, L.A., et al., Differentiating human multipotent mesenchymal stromal cells regulate microRNAs: Prediction of microRNA regulation by PDGF during osteogenesis. Experimental Hematology, 2008. 36(10): p. 1354-1369.
33. Mamidi, M.K., et al., Comparative cellular and molecular analyses of pooled bone marrow multipotent mesenchymal stromal cells during continuous passaging and after successive cryopreservation. Journal of Cellular Biochemistry, 2012. 113(10): p. 3153-3164.
34. Otsuru, S., et al., Improved isolation and expansion of bone marrow mesenchymal stromal cells using a novel marrow filter device. Cytotherapy, 2013. 15(2): p. 146-153.
35. Gronthos, S., et al., THE STRO-1(+) FRACTION OF ADULT HUMAN BONE-MARROW CONTAINS THE OSTEOGENIC PRECURSORS. Blood, 1994. 84(12): p. 4164-4173.
36. Stewart, K., et al., Further characterization of cells expressing STRO-1 in cultures of adult human bone, marrow stromal cells. Journal of Bone and Mineral Research, 1999. 14(8): p. 1345-1356.
37. Pendleton, C., et al., Mesenchymal Stem Cells Derived from Adipose Tissue vs Bone Marrow: In Vitro Comparison of Their Tropism towards Gliomas. Plos One, 2013. 8(3): p. 7.
38. Zhang, X., et al., Isolation and Characterization of Mesenchymal Stem Cells From Human Umbilical Cord Blood: Reevaluation of Critical Factors for Successful Isolation and High Ability to Proliferate and Differentiate to Chondrocytes as Compared to Mesenchymal Stem Cells From Bone Marrow and Adipose Tissue. Journal of Cellular Biochemistry, 2011. 112(4): p. 1206-1218.
39. Gronthos, S., et al., Surface protein characterization of human adipose tissue-derived stromal cells. Journal of Cellular Physiology, 2001. 189(1): p. 54-63.
40. Baglioni, S., et al., Characterization of human adult stem-cell populations isolated from visceral and subcutaneous adipose tissue. Faseb Journal, 2009. 23(10): p. 3494-3505.
41. Kadar, K., et al., DIFFERENTIATION POTENTIAL OF STEM CELLS FROM HUMAN DENTAL ORIGIN - PROMISE FOR TISSUE ENGINEERING. Journal of Physiology and Pharmacology, 2009. 60: p. 167-175.
42. Moretti, P., et al., Mesenchymal Stromal Cells Derived from Human Umbilical Cord Tissues: Primitive Cells with Potential for Clinical and Tissue Engineering Applications, in Bioreactor Systems for Tissue Engineering Ii: Strategies for the Expanison and Directed Differentiation of Stem Cells, C. Kasper, M. VanGriensven, and R. Portner, Editors. 2010, Springer-Verlag Berlin: Berlin. p. 29-54.
43. Denu, R.A., et al., Fibroblasts and Mesenchymal Stromal/Stem Cells Are Phenotypically Indistinguishable. Acta Haematologica, 2016. 136(2): p. 85-97.
44. Van Keymeulen, A., et al., Distinct stem cells contribute to mammary gland development and maintenance. Nature, 2011. 479(7372): p. 189-U58.
45. Delo, D.M., et al., Amniotic fluid and placental stem cells, in Methods in Enzymology. 2006, Elsevier. p. 426-438.
46. Coady, A.M. and S. Bower, Twining′s Textbook of Fetal Abnormalities E-Book: Expert Consult: Online and Print. 2014: Elsevier Health Sciences.
47. Underwood, M.A., W.M. Gilbert, and M.P.J.J.o.p. Sherman, Amniotic fluid: not just fetal urine anymore. 2005. 25(5): p. 341.
48. Eslaminejad, M.B. and S. Jahangir, Amniotic Fluid Stem Cells and Their Application in Cell-Based Tissue Regeneration. International Journal of Fertility & Sterility, 2012. 6(3): p. 147-156.
49. Jarzembowski, J., Genetic Disorders and the Fetus: Diagnosis, Prevention, and Treatment. Pediatric and Developmental Pathology, 2011. 14(1): p. 84-84.
50. Hoehn, H. and D. Salk, . Morphological and Biochemical Heterogeneity of Amniotic Fluid Cells in Culture, in Methods in cell biology. 1982, Elsevier. p. 11-34.
51. GOSDEN, C.M.J.B.m.b., Amniotic fluid cell types and culture. 1983. 39(4): p. 348-354.
52. Prusa, A.R., et al., Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Human Reproduction, 2003. 18(7): p. 1489-1493.
53. Prusa, A.-R. and M.J.M.S.M. Hengstschlager, Amniotic fluid cells and human stem cell research: a new connection. 2002. 8(11): p. RA253-RA257.
54. Kim, J., et al., Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Proliferation, 2007. 40(1): p. 75-90.
55. Tsai, M.S., et al., Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biology of Reproduction, 2006. 74(3): p. 545-551.
56. Simoni, G. and R.J.J.o.p.m. Colognato, The amniotic fluid-derived cells: the biomedical challenge for the third millennium. 2009. 3(3): p. 34.
57. Fauza, D., Amniotic fluid and placental stem cells. Best Practice & Research Clinical Obstetrics & Gynaecology, 2004. 18(6): p. 877-891.
58. Zhang, S.L., et al., The heterogeneity of cell subtypes from a primary culture of human amniotic fluid. Cellular & Molecular Biology Letters, 2010. 15(3): p. 424-439.
59. Jiang, Y.H., et al., Pluripotency of mesenchymal stem cells derived from adult marrow (vol 418, pg 41, 2002). Nature, 2007. 447(7146): p. 879-880.
60. Perrone, L., et al., Postnatal weight change is influenced by mother-newborn pair leptin levels. Nutrition Research, 2000. 20(11): p. 1531-1536.
61. Zambotti, F., et al., Monoamine metabolites and related compounds in human amniotic fluid: Assay by gas chromatography and gas chromatography-mass spectrometry. 1975. 61(3): p. 247-256.
62. Loukogeorgakis, S.P. and P. De Coppi, Concise Review: Amniotic Fluid Stem Cells: The Known, the Unknown, and Potential Regenerative Medicine Applications. Stem Cells, 2017. 35(7): p. 1663-1673.
63. You, Q., et al., The Biological Characteristics of Human Third Trimester Amniotic Fluid Stem Cells. Journal of International Medical Research, 2009. 37(1): p. 105-112.
64. Nadri, S. and M. Soleimani, Comparative analysis of mesenchymal stromal cells from murine bone marrow and amniotic fluid. Cytotherapy, 2007. 9(8): p. 729-737.
65. Fuchs, J.R., et al., Diaphragmatic reconstruction with autologous tendon engineered from mesenchymal amniocytes. Journal of Pediatric Surgery, 2004. 39(6): p. 834-837.
66. Barry, F.P., et al., The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochemical and Biophysical Research Communications, 1999. 265(1): p. 134-139.
67. Barry, F., et al., The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells. Biochemical and Biophysical Research Communications, 2001. 289(2): p. 519-524.
68. Kannagi, R., et al., Stage‐specific embryonic antigens (SSEA‐3 and‐4) are epitopes of a unique globo‐series ganglioside isolated from human teratocarcinoma cells. 1983. 2(12): p. 2355-2361.
69. Tan, S.M., A. Sharma, and J.B. de Haan, Oxidative stress and novel antioxidant approaches to reduce diabetic complications, in Oxidative Stress and Diseases. 2012, IntechOpen.
70. Barlow, S., et al., Comparison of Human Placenta- and Bone Marrow-Derived Multipotent Mesenchymal Stem Cells. Stem Cells and Development, 2008. 17(6): p. 1095-1107.
71. Klemmt, P.A.B., V. Vafaizadeh, and B. Groner, Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. Stem Cell Research & Therapy, 2010. 1: p. 13.
72. Sessarego, N., et al., Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. Haematologica-the Hematology Journal, 2008. 93(3): p. 339-346.
73. De Rosa, A., et al., Amniotic fluid-derived mesenchymal stem cells lead to bone differentiation when cocultured with dental pulp stem cells. 2010. 17(5-6): p. 645-653.
74. Suh, M.R., et al., Human embryonic stem cells express a unique set of microRNAs. Developmental Biology, 2004. 270(2): p. 488-498.
75. Draper, J.S., et al., Surface antigens of human embryonic stem cells: changes upon differentiation in culture. Journal of Anatomy, 2002. 200(3): p. 249-258.
76. Da Sacco, S., R.E. De Filippo, and L. Perin, Amniotic fluid as a source of pluripotent and multipotent stem cells for organ regeneration. Current Opinion in Organ Transplantation, 2011. 16(1): p. 101-105.
77. Kunisaki, S.M., et al., Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials. Journal of Pediatric Surgery, 2007. 42(6): p. 974-980.
78. Miki, T. and S.C. Strom, Amnion-derived pluripotent/multipotent stem cells. Stem Cell Reviews, 2006. 2(2): p. 133-141.
79. Baksh, D., L. Song, and R.S. Tuan, Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. Journal of Cellular and Molecular Medicine, 2004. 8(3): p. 301-316.
80. Ririe, K.M., R.P. Rasmussen, and C.T. Wittwer, Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Analytical Biochemistry, 1997. 245(2): p. 154-160.
81. Shamblott, M.J., et al., Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proceedings of the National Academy of Sciences of the United States of America, 2001. 98(1): p. 113-118.
82. De Coppi, P., et al., Isolation of amniotic stem cell lines with potential for therapy. Nature Biotechnology, 2007. 25(1): p. 100-106.
83. Zheng, Y.B., et al., Characterization and hepatogenic differentiation of mesenchymal stem cells from human amniotic fluid and human bone marrow: A comparative study. Cell Biology International, 2008. 32(11): p. 1439-1448.
84. Zuk, P.A., et al., Human adipose tissue is a source of multipotent stem cells. Molecular Biology of the Cell, 2002. 13(12): p. 4279-4295.
85. Kubista, M., et al., Brca1 regulates in vitro differentiation of mammary epithelial cells. Oncogene, 2002. 21(31): p. 4747-4756.
86. Higuchi, A., et al., Biomimetic Cell Culture Proteins as Extracellular Matrices for Stem Cell Differentiation. Chemical Reviews, 2012. 112(8): p. 4507-4540.
87. Sobacchi, C., et al., Soluble factors on stage to direct mesenchymal stem cells fate. 2017. 5: p. 32.
88. Maes, C., et al., Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. Journal of Clinical Investigation, 2004. 113(2): p. 188-199.
89. Zelzer, E., et al., VEGFA is necessary for chondrocyte survival during bone development. Development, 2004. 131(9): p. 2161-2171.
90. Le Blanc, S., et al., Fibroblast growth factors 1 and 2 inhibit adipogenesis of human bone marrow stromal cells in 3D collagen gels. Experimental Cell Research, 2015. 338(2): p. 136-148.
91. Simann, M., et al., Canonical FGFs Prevent Osteogenic Lineage Commitment and Differentiation of Human Bone Marrow Stromal Cells Via ERK1/2 Signaling. Journal of Cellular Biochemistry, 2017. 118(2): p. 263-275.
92. Choy, L. and R. Derynck, Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. Journal of Biological Chemistry, 2003. 278(11): p. 9609-9619.
93. van Zoelen, E.J., et al., TGFβ-induced switch from adipogenic to osteogenic differentiation of human mesenchymal stem cells: identification of drug targets for prevention of fat cell differentiation. 2016. 7(1): p. 123.
94. Majno, G. and I. Joris, Cells, tissues, and disease: principles of general pathology. 2004: Oxford University Press.
95. Cooper, G.M., R.E. Hausman, and R.E. Hausman, The cell: a molecular approach. Vol. 10. 2000: ASM press Washington, DC.
96. Gelain, F., et al., Designer Self-Assembling Peptide Nanofiber Scaffolds for Adult Mouse Neural Stem Cell 3-Dimensional Cultures. Plos One, 2006. 1(2): p. 11.
97. Ashraf, U., et al., Planting geometry and herbicides for weed control in rice: implications and challenges, in Grasses as Food and Feed. 2018, IntechOpen.
98. Saha, K., et al., Substrate Modulus Directs Neural Stem Cell Behavior. Biophysical Journal, 2008. 95(9): p. 4426-4438.
99. Engler, A.J., et al., Matrix elasticity directs stem cell lineage specification. Cell, 2006. 126(4): p. 677-689.
100. Smith, L.R., S. Cho, and D.E. Discher, Stem Cell Differentiation is Regulated by Extracellular Matrix Mechanics. Physiology, 2018. 33(1): p. 16-25.
101. E. V. Wong, P.D., Cells: Molecules and Mechanisms, in Cells: Molecules and Mechanisms, Chapter 13, ECM & Adhesion. 2009, Axolotl Academic Publishing Company, Louisville, KY. p. 198.
102. Gattazzo, F., A. Urciuolo, and P. Bonaldo, Extracellular matrix: A dynamic microenvironment for stem cell niche. Biochimica Et Biophysica Acta-General Subjects, 2014. 1840(8): p. 2506-2519.
103. He, N.N., et al., Extracellular Matrix can Recover the Downregulation of Adhesion Molecules after Cell Detachment and Enhance Endothelial Cell Engraftment. Scientific Reports, 2015. 5: p. 12.
104. Zhang, J.H., et al., Extracellular Matrix Promotes Highly Efficient Cardiac Differentiation of Human Pluripotent Stem Cells The Matrix Sandwich Method. Circulation Research, 2012. 111(9): p. 1125-1136.
105. Yao, X.P., et al., Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction. Biomaterials, 2015. 60: p. 130-140.
106. Taddei, M.L., et al., Anoikis: an emerging hallmark in health and diseases. Journal of Pathology, 2012. 226(2): p. 380-393.
107. Page-McCaw, A., A.J. Ewald, and Z. Werb, Matrix metalloproteinases and the regulation of tissue remodelling. Nature Reviews Molecular Cell Biology, 2007. 8(3): p. 221-233.
108. Lu, P., et al., Extracellular Matrix Degradation and Remodeling in Development and Disease. Cold Spring Harbor Perspectives in Biology, 2011. 3(12).
109. Theocharis, A.D., et al., Extracellular matrix structure. Advanced Drug Delivery Reviews, 2016. 97: p. 4-27.
110. Stendahl, J.C., D.B. Kaufman, and S.I. Stupp, Extracellular Matrix in Pancreatic Islets: Relevance to Scaffold Design and Transplantation. Cell Transplantation, 2009. 18(1): p. 1-12.
111. Takada, Y., X. Ye, and S. Simon, The integrins. Genome Biology, 2007. 8(5).
112. Langer, R. and J.P. Vacanti, TISSUE ENGINEERING. Science, 1993. 260(5110): p. 920-926.
113. Barbucci, R., Integrated Biomaterials Science. 2002.
114. Daley, W.P., S.B. Peters, and M. Larsen, Extracellular matrix dynamics in development and regenerative medicine. Journal of Cell Science, 2008. 121(3): p. 255-264.
115. Rozario, T. and D.W. DeSimone, The extracellular matrix in development and morphogenesis: A dynamic view. Developmental Biology, 2010. 341(1): p. 126-140.
116. Mullen, P., The Use of Matrigel to Facilitate the Establishment of Human Cancer Lines as Xenografts. Cancer Cell Culture, 2004: p. 287–292.
117. Hughes, C.S., L.M. Postovit, and G.A. Lajoie, Matrigel: A complex protein mixture required for optimal growth of cell culture. Proteomics, 2010. 10(9): p. 1886-1890.
118. Ramshaw, J.A.M., et al., Collagens as biomaterials. Journal of Materials Science-Materials in Medicine, 2009. 20: p. 3-8.
119. Muller, W.E.G., The origin of metazoan complexity: Porifera as integrated animals. Integrative and Comparative Biology, 2003. 43(1): p. 3-10.
120. Silvipriya, K., et al., Collagen: Animal Sources and Biomedical Application. Journal of Applied Pharmaceutical Science, 2015: p. 123-127.
121. Parenteau-Bareil, R., R. Gauvin, and F. Berthod, Collagen-Based Biomaterials for Tissue Engineering Applications. Materials, 2010. 3(3): p. 1863-1887.
122. Hsiao, C.T., et al., Fibronectin in cell adhesion and migration via N-glycosylation. Oncotarget, 2017. 8(41): p. 70653-70668.
123. Erickson, H.P., Stretching fibronectin. Journal of Muscle Research and Cell Motility, 2002. 23(5-6): p. 575-580.
124. Nishida, T., M. Inui, and M. Nomizu, Peptide therapies for ocular surface disturbances based on fibronectin-integrin interactions. Progress in Retinal and Eye Research, 2015. 47: p. 38-63.
125. Savage, B. and Z.M. Ruggeri, Platelet Thrombus Formation in Flowing Blood. PLATELETS, 2013: p. 399–423.
126. Boskey, A.L.R., P. G., The Regulatory Role of Matrix Proteins in Mineralization of Bone. Osteoporosis, 2013: p. 235–255.
127. Maeda, H., et al., Prospective potency of TGF-beta1 on maintenance and regeneration of periodontal tissue. Int Rev Cell Mol Biol, 2013. 304: p. 283-367.
128. Hemeda, H., B. Giebel, and W. Wagner, Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cells. Cytotherapy, 2014. 16(2): p. 170-180.
129. Burnouf, T., et al., Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation? Biomaterials, 2016. 76: p. 371-387.
130. Bieback, K., et al., Human Alternatives to Fetal Bovine Serum for the Expansion of Mesenchymal Stromal Cells from Bone Marrow. Stem Cells, 2009. 27(9): p. 2331-2341.
131. Mannello, F. and G.A. Tonti, Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold! Stem Cells, 2007. 25(7): p. 1603-9.
132. Shih, D.T.B. and T. Burnouf, Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion. New Biotechnology, 2015. 32(1): p. 199-211.
133. Stute, N., et al., Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Experimental Hematology, 2004. 32(12): p. 1212-1225.
134. Shahdadfar, A., et al., In vitro expansion of human mesenchymal stem cells: Choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells, 2005. 23(9): p. 1357-1366.
135. Horn, P., et al., Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells. Cytotherapy, 2010. 12(7): p. 888-898.
136. Kocaoemer, A., et al., Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells, 2007. 25(5): p. 1270-8.
137. Eriksson, L., et al., PLATELET CONCENTRATES IN AN ADDITIVE SOLUTION PREPARED FROM POOLED BUFFY COATS - INVIVO STUDIES. Vox Sanguinis, 1993. 64(3): p. 133-138.
138. Azuma, H., et al., Platelet additive solution - Electrolytes. Transfusion and Apheresis Science, 2011. 44(3): p. 277-281.
139. Doucet, C., et al., Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applications. Journal of Cellular Physiology, 2005. 205(2): p. 228-236.
140. Schallmoser, K., et al., Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion, 2007. 47(8): p. 1436-1446.
141. Kilian, O., et al., Effects of platelet growth factors on human mesenchymal stem cells and human endothelial cells in vitro. European Journal of Medical Research, 2004. 9(7): p. 337-344.
142. Van Pham, P., et al., Activated platelet-rich plasma improves adipose-derived stem cell transplantation efficiency in injured articular cartilage. Stem Cell Research & Therapy, 2013. 4: p. 11.
143. Cervelli, V., et al., Platelet-Rich Plasma Greatly Potentiates Insulin-Induced Adipogenic Differentiation of Human Adipose-Derived Stem Cells Through a Serine/Threonine Kinase Akt-Dependent Mechanism and Promotes Clinical Fat Graft Maintenance. Stem Cells Translational Medicine, 2012. 1(3): p. 206-220.
144. Hara, Y., M. Steiner, and M.G. Baldini, Platelets as a source of growth-promoting factor(s) for tumor cells. Cancer Res, 1980. 40(4): p. 1212-6.
145. Umeno, Y., A. Okuda, and G. Kimura, Proliferative behaviour of fibroblasts in plasma-rich culture medium. J Cell Sci, 1989. 94 ( Pt 3): p. 567-75.
146. King, G.L. and S. Buchwald, Characterization and partial purification of an endothelial cell growth factor from human platelets. J Clin Invest, 1984. 73(2): p. 392-6.
147. Bernardi, M., et al., Production of human platelet lysate by use of ultrasound for ex vivo expansion of human bone marrow-derived mesenchymal stromal cells. Cytotherapy, 2013. 15(8): p. 920-929.
148. Luttenberger, T., et al., Platelet-derived growth factors stimulate proliferation and extracellular matrix synthesis of pancreatic stellate cells: Implications in pathogenesis of pancreas fibrosis. Laboratory Investigation, 2000. 80(1): p. 47-55.
149. Schallmoser, K., et al., Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Engineering Part C-Methods, 2008. 14(3): p. 185-196.
150. Hemeda, H., et al., Heparin concentration is critical for cell culture with human platelet lysate. Cytotherapy, 2013. 15(9): p. 1174-1181.
151. Burnouf, T., et al., A chromatographically purified human TGF-beta1 fraction from virally inactivated platelet lysates. Vox Sang, 2011. 101(3): p. 215-20.
152. Burnouf, T., et al., A virally inactivated platelet-derived growth factor/vascular endothelial growth factor concentrate fractionated from human platelets. Transfusion, 2010. 50(8): p. 1702-1711.
153. Mekaj, Y.H., The roles of platelets in inflammation, immunity, wound healing and malignancy. International Journal of Clinical and Experimental Medicine, 2016. 9(3): p. 5347-5358.
154. Shimizu, K., H. Fujita, and E. Nagamori, Oxygen Plasma-Treated Thermoresponsive Polymer Surfaces for Cell Sheet Engineering. Biotechnology and Bioengineering, 2010. 106(2): p. 303-310.
155. Twaites, B.R., et al., Thermoresponsive polymers as gene delivery vectors: Cell viability, DNA transport and transfection studies. Journal of Controlled Release, 2005. 108(2-3): p. 472-483.
156. Doorty, K.B., et al., Poly(N-isopropylacrylamide) co-polymer films as potential vehicles for delivery of an antimitotic agent to vascular smooth muscle cells. Cardiovascular Pathology, 2003. 12(2): p. 105-110.
157. Stile, R.A. and K.E. Healy, Thermo-responsive peptide-modified hydrogels for tissue regeneration. Biomacromolecules, 2001. 2(1): p. 185-194.
158. Hacker, M.C., et al., Synthesis and Characterization of Injectable, Thermally and Chemically Gelable, Amphiphilic Poly(N-isopropylacrylamide)-Based Macromers. Biomacromolecules, 2008. 9(6): p. 1558-1570.
159. Teotia, A.K., Sami, H., & Kumar, A., Switchable and Responsive Surfaces and Materials for Biomedical Applications. 2015. 3–43.
160. Haq, M.A., Y.L. Su, and D.J. Wang, Mechanical properties of PNIPAM based hydrogels: A review. Materials Science & Engineering C-Materials for Biological Applications, 2017. 70: p. 842-855.
161. Mano, J.F., Stimuli-responsive polymeric systems for biomedical applications. Advanced Engineering Materials, 2008. 10(6): p. 515-527.
162. Janmey, P.A., et al., The hard life of soft cells. 2009. 66(8): p. 597-605.
163. Discher, D.E., P. Janmey, and Y.L. Wang, Tissue cells feel and respond to the stiffness of their substrate. Science, 2005. 310(5751): p. 1139-1143.
164. Xue, W., et al., Synthesis and characterization of hydrophobically modified polyacrylamides and some observations on rheological properties. European Polymer Journal, 2004. 40(1): p. 47-56.
165. Wanwipa Siriwatwechakul, N.T., Vatcharani Ngaotheppitak, and Sureeporn, Thermo-Sensitive Hydrogel: Control of Hydrophilic-Hydrophobic Transition. International Journal of Chemical & Biomolecular Engineering, 2008: p. 165-170.
166. Halperin, A. and M. Kroger, Thermoresponsive Cell Culture Substrates Based on PNIPAM Brushes Functionalized with Adhesion Peptides: Theoretical Considerations of Mechanism and Design. Langmuir, 2012. 28(48): p. 16623-16637.
167. Schwartz, S.D., et al., Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet, 2012. 379(9817): p. 713-20.
168. Osakada, F., et al., In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J Cell Sci, 2009. 122(Pt 17): p. 3169-79.
169. Zaky, S.H., et al., Platelet lysate favours in vitro expansion of human bone marrow stromal cells for bone and cartilage engineering. J Tissue Eng Regen Med, 2008. 2(8): p. 472-81.
170. Zhang, L., et al., ROCK inhibitor Y-27632 suppresses dissociation-induced apoptosis of murine prostate stem/progenitor cells and increases their cloning efficiency. PloS one, 2011. 6(3): p. e18271-e18271.
171. Emre, N., et al., The ROCK Inhibitor Y-27632 Improves Recovery of Human Embryonic Stem Cells after Fluorescence-Activated Cell Sorting with Multiple Cell Surface Markers. Plos One, 2010. 5(8): p. 10.
172. Zhu, J., et al., Inhibition of RhoA/Rho-kinase pathway suppresses the expression of extracellular matrix induced by CTGF or TGF-β in ARPE-19. International journal of ophthalmology, 2013. 6(1): p. 8-14.
173. Leach, L.L., et al., Induced Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium: A Comparative Study Between Cell Lines and Differentiation Methods. J Ocul Pharmacol Ther, 2016. 32(5): p. 317-30. |